Novo Nordisk to smarten up its disposable insulin pens with digital diabetes devicemaker Biocorp | Fierce Biotech
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases | Business Wire
Waiting doesn't work' says new research on obesity in kids | Daily Sentinel
Novo Nordisk: This Winner Has Risks, Be Aware (NYSE:NVO) | Seeking Alpha
Novo Nordisk maintains strong growth in T2D against competitor Lilly - Pharmaceutical Technology
Novo Nordisk - Home | Facebook
Novo Nordisk - Wikipedia
Novo Nordisk, a leader in global healthcare, selects Qualified
Novo Nordisk adding hundreds of jobs in Johnston County over next decade - Triangle Business Journal
Novo Nordisk apologises for not disclosing sponsorship of anti-obesity training | Financial Times
Novo Nordisk Brokers Another Deal in Fight Against Obesity | BioSpace
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
Novo Nordisk Patient Assistance Program (PAP) | NovoCare®
R&D pipeline
Novo Nordisk Foundation - Wikipedia
Sweet Relief for Diabetes: Novo Nordisk (NVO) - Clean Yield
Novo Nordisk Pharmatech A/S - Cell 2023
Texas Covered Silver Sponsor: Novo Nordisk
Novo Nordisk comments on role of off-label use in Ozempic shortfall
